178 studies found for:    Nanoparticles
Show Display Options
Rank Status Study
1 Withdrawn C-VISA BikDD: Liposome in Advanced Pancreatic Cancer
Condition: Pancreatic Cancer
Intervention: Genetic: BikDD Nanoparticle
2 Unknown  Pilot Study - Putative Penetration of Nanoparticles in Sunscreen in Intact or Sunburned Skin
Conditions: Healthy Skin;   Sunburned Skin;   Titanium Dioxide;   Nanoparticles;   Penetrate Skin
Intervention:
3 Recruiting Clinical Study on the Harvesting Lymph Nodes With Carbon Nanoparticles for Advanced Gastric Cancer
Condition: Advanced Gastric Cancer
Interventions: Drug: Carbon Nanoparticles;   Procedure: Gastrectomy with D2 dissection
4 Active, not recruiting Fluor Varnish With Silver Nanoparticles for Dental Remineralization in Patients With Trisomy 21
Condition: Down Syndrome
Interventions: Drug: Fluor varnish;   Drug: Fluor varnish with nanoparticles
5 Active, not recruiting Capsaicin Nanoparticle in Patient With Painful Diabetic Neuropathy
Condition: Painful Diabetic Neuropathy
Interventions: Drug: 0.75% capsaicin nanoparticle cream;   Drug: Placebo
6 Unknown  Antibacterial Properties of Silicon Incorporated With Quaternary Ammonium Polyethylenimine Nanoparticles
Condition: Carcinoma of Head and Neck
Intervention: Device: polyethylenimine (PEI) nanoparticles.
7 Recruiting Magnetic Nanoparticle Thermoablation-Retention and Maintenance in the Prostate:A Phase 0 Study in Men
Condition: Prostate Cancer
Intervention: Other: Magnetic Nanoparticle Injection
8 Recruiting Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Older Patients With Locally Advanced or Metastatic Breast Cancer
Conditions: Male Breast Cancer;   Recurrent Breast Cancer;   Stage IV Breast Cancer;   Estrogen Receptor-negative Breast Cancer;   Estrogen Receptor-positive Breast Cancer;   HER2-negative Breast Cancer;   HER2-positive Breast Cancer;   Progesterone Receptor-negative Breast Cancer;   Progesterone Receptor-positive Breast Cancer;   Stage IIIA Breast Cancer;   Stage IIIB Breast Cancer;   Stage IIIC Breast Cancer;   Triple-negative Breast Cancer
Interventions: Drug: paclitaxel albumin-stabilized nanoparticle formulation;   Other: questionnaire administration
9 Recruiting Nanoparticles in Nasal Mucosa
Conditions: Chronic Hypertrophic Rhinosinusitis;   Chronic Polypous Rhinosinusitis
Intervention: Procedure: Mucotomy
10 Not yet recruiting Selinexor, Gemcitabine Hydrochloride, and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Metastatic Pancreatic Cancer
Conditions: Acinar Cell Adenocarcinoma of the Pancreas;   Duct Cell Adenocarcinoma of the Pancreas;   Stage IV Pancreatic Cancer
Interventions: Drug: gemcitabine hydrochloride;   Drug: paclitaxel albumin-stabilized nanoparticle formulation;   Drug: selinexor;   Other: pharmacological study;   Other: laboratory biomarker analysis
11 Completed
Has Results
Use of Nanoparticle Paclitaxel (ABI-007) for the Prevention of In-Stent Restenosis
Condition: Coronary Restenosis
Intervention: Drug: Nanoparticle Paclitaxel
12 Unknown  The Differential Pattern of Deposition of Nano Particles in the Airways of Exposed Workers
Condition: Inadequate or Impaired Respiratory Function
Intervention:
13 Not yet recruiting Dovitinib Lactate, Gemcitabine Hydrochloride, and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Solid Tumors or Pancreatic Cancer
Conditions: Duct Cell Adenocarcinoma of the Pancreas;   Recurrent Pancreatic Cancer;   Stage III Pancreatic Cancer;   Stage IV Pancreatic Cancer;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: dovitinib lactate;   Drug: gemcitabine hydrochloride;   Drug: paclitaxel albumin-stabilized nanoparticle formulation;   Other: pharmacological study;   Other: laboratory biomarker analysis
14 Recruiting Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Carboplatin Followed By Chemoradiation in Treating Patients With Recurrent Head and Neck Cancer
Conditions: Recurrent Salivary Gland Cancer;   Recurrent Squamous Cell Carcinoma of the Hypopharynx;   Recurrent Squamous Cell Carcinoma of the Larynx;   Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity;   Recurrent Squamous Cell Carcinoma of the Nasopharynx;   Recurrent Squamous Cell Carcinoma of the Oropharynx;   Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity;   Recurrent Verrucous Carcinoma of the Larynx;   Recurrent Verrucous Carcinoma of the Oral Cavity;   Salivary Gland Squamous Cell Carcinoma;   Tongue Cancer
Interventions: Drug: carboplatin;   Drug: paclitaxel albumin-stabilized nanoparticle formulation;   Drug: fluorouracil;   Drug: hydroxyurea;   Procedure: therapeutic conventional surgery;   Radiation: radiation therapy;   Radiation: hyperfractionated radiation therapy;   Other: laboratory biomarker analysis
15 Unknown  A Clinical Trial to Study the Effects of Nanoparticle Based Paclitaxel Drug, Which Does Not Contain the Solvent Cremophor, in Advanced Breast Cancer
Condition: Advanced Breast Cancer
Intervention: Drug: Nanoxel (Paclitaxel Nanoparticle formulation )
16 Recruiting Intraperitoneal Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Cancer of the Peritoneal Cavity
Conditions: Ovarian Cancer;   Peritoneal Cavity Cancer;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: paclitaxel albumin-stabilized nanoparticle formulation;   Other: liquid chromatography;   Other: mass spectrometry;   Other: pharmacological study;   Other: laboratory biomarker analysis
17 Not yet recruiting Neoadjuvant Chemotherapy of Nanoparticle Albumin-bound Paclitaxel in Lung Cancer
Condition: Non Small Cell Lung Cancer
Intervention: Drug: nanoparticle albumin-bound paclitaxel
18 Recruiting Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Previously Treated Advanced Non-Small Cell Lung Cancer
Conditions: Recurrent Non-small Cell Lung Cancer;   Stage IV Non-small Cell Lung Cancer
Interventions: Drug: paclitaxel albumin-stabilized nanoparticle formulation;   Other: laboratory biomarker analysis
19 Not yet recruiting Ceritinib and Combination Chemotherapy in Treating Patients With Advanced Solid Tumors or Locally Advanced or Metastatic Pancreatic Cancer
Conditions: Acinar Cell Adenocarcinoma of the Pancreas;   Duct Cell Adenocarcinoma of the Pancreas;   Recurrent Pancreatic Cancer;   Stage III Pancreatic Cancer;   Stage IV Pancreatic Cancer;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: ceritinib;   Drug: gemcitabine hydrochloride;   Drug: paclitaxel albumin-stabilized nanoparticle formulation;   Drug: cisplatin;   Other: laboratory biomarker analysis;   Other: pharmacological study
20 Recruiting Neoadjuvant Chemotherapy of Nanoparticle Albumin-bound Paclitaxel/Carboplatin vs. Paclitaxel /Carboplatin in Stage Ⅱ B and IIIA Squamous Cell Carcinoma of the Lung
Condition: Non-small Cell Lung Cancer
Intervention: Drug: nanoparticle albumin-bound paclitaxel/carboplatin

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years